GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 61 filers reported holding GALECTIN THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $205 | +40.4% | 106,522 | +4.9% | 0.00% | – |
| Q2 2023 | $146 | -31.5% | 101,522 | 0.0% | 0.00% | – |
| Q1 2023 | $213 | +86.8% | 101,522 | 0.0% | 0.00% | – |
| Q4 2022 | $114 | -99.8% | 101,522 | +165.6% | 0.00% | – |
| Q3 2022 | $62,000 | +24.0% | 38,220 | 0.0% | 0.00% | – |
| Q2 2022 | $50,000 | +16.3% | 38,220 | +42.1% | 0.00% | – |
| Q1 2022 | $43,000 | +26.5% | 26,902 | +59.2% | 0.00% | – |
| Q4 2021 | $34,000 | -26.1% | 16,902 | +42.0% | 0.00% | – |
| Q3 2021 | $46,000 | -23.3% | 11,902 | -27.2% | 0.00% | – |
| Q3 2019 | $60,000 | -4.8% | 16,352 | +7.2% | 0.00% | – |
| Q2 2019 | $63,000 | +1.6% | 15,247 | +25.1% | 0.00% | – |
| Q1 2019 | $62,000 | +63.2% | 12,188 | +8.9% | 0.00% | – |
| Q4 2018 | $38,000 | – | 11,188 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cutter & CO Brokerage, Inc. | 129,488 | $248,617 | 0.07% |
| Geneos Wealth Management Inc. | 417,350 | $801,312 | 0.04% |
| SHEPHERD KAPLAN KROCHUK, LLC | 12,000 | $23,040 | 0.02% |
| RETIREMENT GUYS FORMULA LLC | 11,500 | $22,080 | 0.02% |
| Vivaldi Capital Management LP | 19,261 | $36,981 | 0.01% |
| OSAIC HOLDINGS, INC. | 3,275,192 | $6,288,345 | 0.01% |
| Traynor Capital Management, Inc. | 34,707 | $66,638 | 0.01% |
| Atria Wealth Solutions, Inc. | 259,800 | $498,816 | 0.01% |
| BARRETT & COMPANY, INC. | 4,984 | $9,569 | 0.01% |
| Wealthspire Advisors, LLC | 183,862 | $353,016 | 0.01% |